251 related articles for article (PubMed ID: 13130388)
21. Efficacy and tolerability of Ginkgo biloba extract EGb 761® in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials.
Gauthier S; Schlaefke S
Clin Interv Aging; 2014; 9():2065-77. PubMed ID: 25506211
[TBL] [Abstract][Full Text] [Related]
22. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R
Pharmacopsychiatry; 1996 Mar; 29(2):47-56. PubMed ID: 8741021
[TBL] [Abstract][Full Text] [Related]
23. Ginkgo biloba special extract EGb 761 in generalized anxiety disorder and adjustment disorder with anxious mood: a randomized, double-blind, placebo-controlled trial.
Woelk H; Arnoldt KH; Kieser M; Hoerr R
J Psychiatr Res; 2007 Sep; 41(6):472-80. PubMed ID: 16808927
[TBL] [Abstract][Full Text] [Related]
24. Plant-based nutraceutical interventions against cognitive impairment and dementia: meta-analytic evidence of efficacy of a standardized Gingko biloba extract.
Solfrizzi V; Panza F
J Alzheimers Dis; 2015; 43(2):605-11. PubMed ID: 25352453
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of a Ginkgo biloba extract.
Le Bars PL; Kastelan J
Public Health Nutr; 2000 Dec; 3(4A):495-9. PubMed ID: 11276297
[TBL] [Abstract][Full Text] [Related]
26. [Tanakan (EGb 761) in the therapy of mild cognitive impairment].
Iakhno NN; Zakharov VV; Lokshina AB; Gavrilova SI; Fedorova IaB; Gustov AV; Korshunova IuA; Dziak LA; Miziakina EV; Odinak MM; Emelin AIu; PilipenkoP I ; Vostrikova EV
Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(12):41-6. PubMed ID: 17274394
[TBL] [Abstract][Full Text] [Related]
27. Ginkgo extract or cholinesterase inhibitors in patients with dementia: what clinical trials and guidelines fail to consider.
Schulz V
Phytomedicine; 2003; 10 Suppl 4():74-9. PubMed ID: 12807348
[TBL] [Abstract][Full Text] [Related]
28. The pharmacological effects of ginkgo biloba, a plant extract, on the brain of dementia patients in comparison with tacrine.
Itil TM; Eralp E; Ahmed I; Kunitz A; Itil KZ
Psychopharmacol Bull; 1998; 34(3):391-7. PubMed ID: 9803773
[TBL] [Abstract][Full Text] [Related]
29. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
Kasper S; Schubert H
Fortschr Neurol Psychiatr; 2009 Sep; 77(9):494-506. PubMed ID: 19621278
[TBL] [Abstract][Full Text] [Related]
30. [Ginkgo special extract EGb 761 in tinnitus therapy. An overview of results of completed clinical trials].
Holstein N
Fortschr Med Orig; 2001 Jan; 118(4):157-64. PubMed ID: 11217680
[TBL] [Abstract][Full Text] [Related]
31. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S
J Psychiatr Res; 2012 Jun; 46(6):716-23. PubMed ID: 22459264
[TBL] [Abstract][Full Text] [Related]
32. Strategies for the use of Ginkgo biloba extract, EGb 761
Kandiah N; Chan YF; Chen C; Dasig D; Dominguez J; Han SH; Jia J; Kim S; Limpawattana P; Ng LL; Nguyen DT; Ong PA; Raya-Ampil E; Saedon N; Senanarong V; Setiati S; Singh H; Suthisisang C; Trang TM; Turana Y; Venketasubramanian N; Yong FM; Youn YC; Ihl R
CNS Neurosci Ther; 2021 Feb; 27(2):149-162. PubMed ID: 33352000
[TBL] [Abstract][Full Text] [Related]
33. A brief history of EGb 761 and its therapeutic uses.
DeFeudis FV
Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S2-7. PubMed ID: 13130382
[No Abstract] [Full Text] [Related]
34. Gingko biloba extract EGb 761®: clinical data in dementia.
Ihl R
Int Psychogeriatr; 2012 Aug; 24 Suppl 1():S35-40. PubMed ID: 22784427
[TBL] [Abstract][Full Text] [Related]
35. Effects of Ginkgo biloba extract EGb 761 on neuropsychiatric symptoms of dementia: findings from a randomised controlled trial.
Scripnikov A; Khomenko A; Napryeyenko O;
Wien Med Wochenschr; 2007; 157(13-14):295-300. PubMed ID: 17704975
[TBL] [Abstract][Full Text] [Related]
36. Association of Alzheimer's disease onset with ginkgo biloba and other symptomatic cognitive treatments in a population of women aged 75 years and older from the EPIDOS study.
Andrieu S; Gillette S; Amouyal K; Nourhashemi F; Reynish E; Ousset PJ; Albarede JL; Vellas B; Grandjean H;
J Gerontol A Biol Sci Med Sci; 2003 Apr; 58(4):372-7. PubMed ID: 12663701
[TBL] [Abstract][Full Text] [Related]
37. Ginkgo biloba special extract EGb 761 in the treatment of peripheral arterial occlusive disease (PAOD)--a review based on randomized, controlled studies.
Horsch S; Walther C
Int J Clin Pharmacol Ther; 2004 Feb; 42(2):63-72. PubMed ID: 15180165
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic efficacy of the Ginkgo special extract EGb761
Müller WE; Eckert A; Eckert GP; Fink H; Friedland K; Gauthier S; Hoerr R; Ihl R; Kasper S; Möller HJ
World J Biol Psychiatry; 2019 Mar; 20(3):173-189. PubMed ID: 28460580
[TBL] [Abstract][Full Text] [Related]
39. No alteration in the PFA-100 in vitro bleeding time induced by the Ginkgo biloba special extract, EGb 761, in elderly patients with mild cognitive impairment.
Halil M; Cankurtaran M; Yavuz BB; Ozkayar N; Ulger Z; Dede DS; Shorbagi A; Buyukasik Y; Haznedaroglu IC; Arogul S
Blood Coagul Fibrinolysis; 2005 Jul; 16(5):349-53. PubMed ID: 15970719
[TBL] [Abstract][Full Text] [Related]
40. Baseline neuropsychiatric symptoms are effect modifiers in Ginkgo biloba extract (EGb 761®) treatment of dementia with neuropsychiatric features. Retrospective data analyses of a randomized controlled trial.
Ihl R; Tribanek M; Bachinskaya N
J Neurol Sci; 2010 Dec; 299(1-2):184-7. PubMed ID: 20837354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
